ReviewJournal of gynecologic oncology2023

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.

Jung-Yun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.